Schridde H, Hickl E J
Geburtshilfe Frauenheilkd. 1978 Oct;38(10):845-8.
15(S)-15-Methyl-Prostaglandin F2alpha was applied intramuscular to end 27 intact pregnancies mainly in the second trimenon and to induce abortion in 5 cases of disturbed pregnancy. The results showed a similar success of 90 percent in the cases of interruptions compared with the natural prostaglandins applied either extra- or intraamniotic; in the mean induction-abortion-interval of 16 hours the 15(S)-15-Methyl-Prostaglandin F2alpha is better than natural prostaglandins. It is much simpler to apply, the dosage is less. The initial dose is 250 mcg intramuscular, further doses depend on the success achieved, the effect on the bowel activity may be used as indicator. The intramuscular method avoids complications connected with the intraamniotic application, infections of the intracervical catheter lying for a long time and the severe side effects of the intravenous application. In cases of missed abortion and hydatidiform moles, where the use of natural prostaglandins is problematic, the use of 15(S)-15-Methyl-Prostaglandin F2alpha is a progress in this form of therapy.
15(S)-15-甲基前列腺素F2α主要在妊娠中期经肌肉注射用于终止27例正常妊娠,并用于5例异常妊娠的引产。结果显示,与经羊膜外或羊膜内应用天然前列腺素相比,15(S)-15-甲基前列腺素F2α引产成功率相似,均为90%;在平均引产-流产间隔时间16小时方面,15(S)-15-甲基前列腺素F2α优于天然前列腺素。其应用更简便,剂量更小。初始剂量为肌肉注射250微克,后续剂量取决于引产效果,可将肠道活动情况作为指标。肌肉注射法可避免与羊膜内应用相关的并发症,如长时间留置宫颈导管引起的感染以及静脉应用的严重副作用。在稽留流产和葡萄胎病例中,使用天然前列腺素存在问题,而使用15(S)-15-甲基前列腺素F2α是这种治疗方式的一大进展。